James J Gilhool, DO | |
1855 Powder Mill Rd, York, PA 17402-4723 | |
(717) 848-4800 | |
(717) 741-9867 |
Full Name | James J Gilhool |
---|---|
Gender | Male |
Speciality | Physical Medicine And Rehabilitation |
Experience | 29 Years |
Location | 1855 Powder Mill Rd, York, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295700599 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Oss Orthopaedic Hospital | York, PA | Hospital |
York Hospital | York, PA | Hospital |
Upmc Memorial | York, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Oss Orthopaedic Hospital Llc | 8729110747 | 105 |
News Archive
The University of Minnesota is the first institution in the state to participate in the phase III clinical trial for CardiAmp Therapy. Previous clinical studies of this therapy have been promising and have shown improvements in patients' quality of life and heart function.
BioScrip, Inc. today announced 2015 second quarter financial results. Second quarter revenue from continuing operations was $262.4 million and the net loss from continuing operations was $243.2 million, or $3.60 loss per diluted share, which includes a $238.0 million pre-tax goodwill impairment charge resulting from a decline in the Company's common stock price and related market capitalization, as well as an $8.6 million incremental pre-tax bad debt charge predominately attributable to aged accounts receivable balances over 365 days old.
Transfusion practices significantly predict early inhospital mortality among adult trauma patients, suggests a report published in the Archives of Surgery.
Tuberculosisis the number one infectious disease killer worldwide. Particularly in hard-to-reach populations, diagnosis and treatment of TB remains very challenging.
› Verified 9 days ago
Entity Name | Oss Orthopaedic Hospital Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578881652 PECOS PAC ID: 8729110747 Enrollment ID: O20110915000770 |
News Archive
The University of Minnesota is the first institution in the state to participate in the phase III clinical trial for CardiAmp Therapy. Previous clinical studies of this therapy have been promising and have shown improvements in patients' quality of life and heart function.
BioScrip, Inc. today announced 2015 second quarter financial results. Second quarter revenue from continuing operations was $262.4 million and the net loss from continuing operations was $243.2 million, or $3.60 loss per diluted share, which includes a $238.0 million pre-tax goodwill impairment charge resulting from a decline in the Company's common stock price and related market capitalization, as well as an $8.6 million incremental pre-tax bad debt charge predominately attributable to aged accounts receivable balances over 365 days old.
Transfusion practices significantly predict early inhospital mortality among adult trauma patients, suggests a report published in the Archives of Surgery.
Tuberculosisis the number one infectious disease killer worldwide. Particularly in hard-to-reach populations, diagnosis and treatment of TB remains very challenging.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
James J Gilhool, DO 1861 Powder Mill Rd, Attn Medical Staff Office, York, PA 17402-4723 Ph: (717) 718-2041 | James J Gilhool, DO 1855 Powder Mill Rd, York, PA 17402-4723 Ph: (717) 848-4800 |
News Archive
The University of Minnesota is the first institution in the state to participate in the phase III clinical trial for CardiAmp Therapy. Previous clinical studies of this therapy have been promising and have shown improvements in patients' quality of life and heart function.
BioScrip, Inc. today announced 2015 second quarter financial results. Second quarter revenue from continuing operations was $262.4 million and the net loss from continuing operations was $243.2 million, or $3.60 loss per diluted share, which includes a $238.0 million pre-tax goodwill impairment charge resulting from a decline in the Company's common stock price and related market capitalization, as well as an $8.6 million incremental pre-tax bad debt charge predominately attributable to aged accounts receivable balances over 365 days old.
Transfusion practices significantly predict early inhospital mortality among adult trauma patients, suggests a report published in the Archives of Surgery.
Tuberculosisis the number one infectious disease killer worldwide. Particularly in hard-to-reach populations, diagnosis and treatment of TB remains very challenging.
› Verified 9 days ago
Ashley Delserro, RN Pain Medicine Medicare: Medicare Enrolled Practice Location: 4075 E Market St Ste 20, York, PA 17402 Phone: 717-244-8504 Fax: 717-244-5401 | |
Edward S Kim, D.O. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 228 Saint Charles Way Ste 300, York, PA 17402 Phone: 717-812-2055 Fax: 717-741-3784 |